Section Arrow
Quote
CALT.NASDAQ
- Calliditas Therapeutics AB
Quotes are at least 15-min delayed:2024/05/16 14:02 EDT
Last
 22.0299
-0.1069 (-0.48%)
Day High 
22.0299 
Prev. Close
22.1368 
1-M High
22.8999 
Volume 
854 
Bid
20.8
Ask
22.03
Day Low
21.9006 
Open
21.9006 
1-M Low
16 
Market Cap 
594.06M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 20.7 
20-SMA 19.72 
50-SMA 20.74 
52-W High 29.3 
52-W Low 15.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-17.38/1.75
Enterprise Value
1.56B
Balance Sheet
Book Value Per Share
1.15
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.21B
Operating Revenue Per Share
4.04
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1142+0.0365+46.98%-- 
NBYNovaBay Pharmaceuticals0.126+0.0215+20.57%-- 
DNAGinkgo Bioworks Holdings0.8347-0.0044-0.52%-- 
JAGXJaguar Health0.279+0.0239+9.37%-- 
NVAXNovavax13.932+1.032+8.00%-- 
Quotes are at least 15-min delayed：2024/05/16 14:02 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, initially focusing on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.